NCT03250065

Brief Summary

This proposal describes the development of a 'Sensing ET Tube'. This device will replace the standard endotracheal (ET) tube used in anaesthesia and in ventilated intensive care patients and provide key vital signs monitoring utilising optoelectronic sensors. Continuous monitoring of patients' arterial oxygen saturation is essential during surgery, however pulse oximeters often misread or fail altogether as a result of peripheral vasoconstriction, hypotension or hypovolaemia. The Sensing ET Tube will allow continuous measurement of oxygen saturation and other parameters, such as pulse rate, from a single internal site, and will reduce the number of surface sensors placed on the skin and the number of electrical connections to the patient. The applicants have already developed similar sensor technology in the oesophagus and other internal locations. A pilot clinical evaluation of the device will be completed in anaesthetised patients undergoing surgery. The project will lead to further development of a multi-sensor tracheal platform for comprehensive anaesthesia and intensive care monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 15, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2017

Completed
Last Updated

February 12, 2018

Status Verified

February 1, 2018

Enrollment Period

5 months

First QC Date

August 9, 2017

Last Update Submit

February 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • To validate the pulse oximetry signals from the trachea during anaesthesia for their suitability in determining vital signs, not limited to just oxygen saturation.

    Raw optical electrical signals related to the absorbion of red and infrared light from the prototype sensor by the tissue in the trachea will be assessed for their viability to reliable determine pulse rate and oxygen saturation compared to the standard clinical devices during surgery. The signals will be further analysed to look for correlation with recorded blood pressure measurents and respiration rates.

    1 year

Study Arms (1)

ETT Study Group

EXPERIMENTAL

The Sensing ET Tube study Group

Device: Application of prototype sensor to a standard endotracheal tube

Interventions

During anaesthesia the device under study, a prototype saturation sensor will be applied to a standard endotracheal tube that ventilates the patient as normal.

ETT Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-III
  • Years and older
  • Undergoing elective surgery requiring general anaesthesia, and endotracheal tube as part of their anaesthetic.

You may not qualify if:

  • Those who refuse consent
  • Known or potentially difficult airway
  • Respiratory conditions including severe asthma, COPD, lung cancer etc.
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

City, University of London

London, EC1V0HB, United Kingdom

Location

Barts and The London NHS Trust

London, United Kingdom

Location

Study Officials

  • Saowarat Snidvongs, MD

    Barts and The London NHS Trust

    PRINCIPAL INVESTIGATOR
  • Justin Phillips, PhD

    City, University of London

    STUDY DIRECTOR
  • Panayiotis A Kyriacou, PhD

    City, University of London

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2017

First Posted

August 15, 2017

Study Start

March 3, 2017

Primary Completion

July 31, 2017

Study Completion

September 30, 2017

Last Updated

February 12, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

all data is anonymised and raw signals are only shared among the named investigators

Locations